Detalles de la búsqueda
1.
Characterizing the Sources of Pharmacokinetic Variability for TAK-117 (Serabelisib), an Investigational Phosphoinositide 3-Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy.
Clin Pharmacol Drug Dev
; 8(5): 637-646, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30168905
2.
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.
Drug Saf
; 41(8): 807-816, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29737503
Resultados
1 -
2
de 2
1
Próxima >
>>